New potent acetylcholinesterase inhibitors in the tetracyclic triterpene series.

Article Details

Citation
Copy to clipboard

Sauvaitre T, Barlier M, Herlem D, Gresh N, Chiaroni A, Guenard D, Guillou C

New potent acetylcholinesterase inhibitors in the tetracyclic triterpene series.

J Med Chem. 2007 Nov 1;50(22):5311-23. Epub 2007 Sep 29.

PubMed ID
17902635 [ View in PubMed
]
Abstract

A new highly selective inhibitor of acetylcholinesterase (AChE) was discovered by high-throughput screening. Compound 1 was synthesized from a natural product, the N-3-isobutyrylcycloxobuxidine-F 2. A new extraction protocol of this compound is described. The hemisynthesis and optimization of 1 are reported. The analogs of 1 were tested in vitro for the inhibition of both cholinesterases (AChE and BuChE). These compounds selectively inhibited AChE. Extensive molecular docking studies were performed with 2 and AChE employing Discover Biosym software to rationalize the binding interaction. The results suggested that ligand 2 binds simultaneously to both catalytic and peripheral sites of AChE.

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
TacrineAcetylcholinesteraseIC 50 (nM)1030825Details